Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Weijian Pharmaceutical Group Co.

Request full access

Weijian Pharmaceuticals is a new pharmaceutical company that promotes the development of China's pharmaceutical health industry

Hong KongFounded 2006Biotech & Life Sciences

About Weijian Pharmaceutical Group Co.

Winhealth Pharma operates in the pharmaceutical industry, focusing on the development and distribution of innovative treatments for rare diseases and inflammatory conditions. The company serves a diverse client base, including underprivileged children and patients with specific medical needs. Winhealth Pharma collaborates with upstream manufacturers and other pharmaceutical companies to ensure the availability of critical medications, such as Lonafarnib for HGPS patients and treatments for inflammatory bowel disease. The company’s business model revolves around strategic partnerships and public welfare programs, which help them to make essential medications accessible to those in need. Revenue is generated through the import and distribution of these specialized drugs, as well as through collaborations with other pharmaceutical entities. Winhealth Pharma is committed to result-driven innovation, responsible practices, and entrepreneurial initiatives to continuously improve patient outcomes and address unmet medical needs.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
18.3/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Disease, Biotech and Pharma, Rare Diseases, Hard Tech, DT and LS, science-based
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Aug 2018 $10M $40M Kaitai Capital —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Weijian Pharmaceutical Group Co. website traffic

Latest recorded traffic for Weijian Pharmaceutical Group Co. is 580 monthly website visits, up 0% over the last three months.

Latest monthly visits580 3-month web change0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Weijian Pharmaceutical Group Co. in its local ecosystem

Live from Dealroom

The Weijian Pharmaceutical Group Co. office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Kaitai Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇭🇰 Hong Kong HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Weijian Pharmaceutical Group Co. on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Weijian Pharmaceutical Group Co.’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.